FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783303183> ?p ?o ?g. }

• W2783303183 abstract "Building on an approach applied to cardiovascular and cancer research, we estimated the economic returns from United Kingdom public- and charitable-funded musculoskeletal disease (MSD) research that arise from the net value of the improved health outcomes in the United Kingdom.To calculate the economic returns from MSD-related research in the United Kingdom, we estimated (1) the public and charitable expenditure on MSD-related research in the United Kingdom between 1970 and 2013; (2) the net monetary benefit (NMB), derived from the health benefit in quality adjusted life years (QALYs) valued in monetary terms (using a base-case value of a QALY of £25,000) minus the cost of delivering that benefit, for a prioritised list of interventions from 1994 to 2013; (3) the proportion of NMB attributable to United Kingdom research; and (4) the elapsed time between research funding and health gain. The data collected from these four key elements were used to estimate the internal rate of return (IRR) from MSD-related research investments on health benefits. We analysed the uncertainties in the IRR estimate using a one-way sensitivity analysis.Expressed in 2013 prices, total expenditure on MSD-related research from 1970 to 2013 was £3.5 billion, and for the period used to estimate the rate of return, 1978-1997, was £1.4 billion. Over the period 1994-2013 the key interventions analysed produced 871,000 QALYs with a NMB of £16 billion, allowing for the net NHS costs resulting from them and valuing a QALY at £25,000. The proportion of benefit attributable to United Kingdom research was 30% and the elapsed time between funding and impact of MSD treatments was 16 years. Our best estimate of the IRR from MSD-related research was 7%, which is similar to the 9% for CVD and 10% for cancer research.Our estimate of the IRR from the net health gain to public and charitable funding of MSD-related research in the United Kingdom is substantial, and justifies the research investments made between 1978 and 1997. We also demonstrated the applicability of the approach previously used in assessing the returns from cardiovascular and cancer research. Inevitably, with a study of this kind, there are a number of important assumptions and caveats that we highlight, and these can inform future research." @default.
• W2783303183 created "2018-01-26" @default.
• W2783303183 creator A5017148517 @default.
• W2783303183 creator A5032643048 @default.
• W2783303183 creator A5060103038 @default.
• W2783303183 creator A5061577383 @default.
• W2783303183 creator A5067851860 @default.
• W2783303183 creator A5078178102 @default.
• W2783303183 creator A5080425689 @default.
• W2783303183 date "2018-01-10" @default.
• W2783303183 modified "2023-10-18" @default.
• W2783303183 title "Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomes" @default.
• W2783303183 cites W166560170 @default.
• W2783303183 cites W1975164223 @default.
• W2783303183 cites W1979025931 @default.
• W2783303183 cites W2025608732 @default.
• W2783303183 cites W2025776410 @default.
• W2783303183 cites W2031508102 @default.
• W2783303183 cites W2047757958 @default.
• W2783303183 cites W2050416115 @default.
• W2783303183 cites W2050885682 @default.
• W2783303183 cites W2055038989 @default.
• W2783303183 cites W2081818270 @default.
• W2783303183 cites W2092063686 @default.
• W2783303183 cites W2093766894 @default.
• W2783303183 cites W2094843447 @default.
• W2783303183 cites W2095734644 @default.
• W2783303183 cites W2102987799 @default.
• W2783303183 cites W2106344037 @default.
• W2783303183 cites W2124354030 @default.
• W2783303183 cites W2127969732 @default.
• W2783303183 cites W2128649547 @default.
• W2783303183 cites W2137203336 @default.
• W2783303183 cites W2137752316 @default.
• W2783303183 cites W2142149055 @default.
• W2783303183 cites W2144629504 @default.
• W2783303183 cites W2145638966 @default.
• W2783303183 cites W2153538330 @default.
• W2783303183 cites W2154461664 @default.
• W2783303183 cites W2168729355 @default.
• W2783303183 cites W2270992578 @default.
• W2783303183 cites W2274253041 @default.
• W2783303183 cites W2282615105 @default.
• W2783303183 cites W2346701512 @default.
• W2783303183 cites W2347164991 @default.
• W2783303183 cites W2533200693 @default.
• W2783303183 cites W2585856210 @default.
• W2783303183 cites W2963128170 @default.
• W2783303183 cites W4234112509 @default.
• W2783303183 doi "https://doi.org/10.1186/s12961-017-0276-7" @default.
• W2783303183 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5761203" @default.
• W2783303183 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29316935" @default.
• W2783303183 hasPublicationYear "2018" @default.
• W2783303183 type Work @default.
• W2783303183 sameAs 2783303183 @default.
• W2783303183 citedByCount "93" @default.
• W2783303183 countsByYear W27833031832016 @default.
• W2783303183 countsByYear W27833031832018 @default.
• W2783303183 countsByYear W27833031832019 @default.
• W2783303183 countsByYear W27833031832020 @default.
• W2783303183 countsByYear W27833031832021 @default.
• W2783303183 countsByYear W27833031832022 @default.
• W2783303183 countsByYear W27833031832023 @default.
• W2783303183 crossrefType "journal-article" @default.
• W2783303183 hasAuthorship W2783303183A5017148517 @default.
• W2783303183 hasAuthorship W2783303183A5032643048 @default.
• W2783303183 hasAuthorship W2783303183A5060103038 @default.
• W2783303183 hasAuthorship W2783303183A5061577383 @default.
• W2783303183 hasAuthorship W2783303183A5067851860 @default.
• W2783303183 hasAuthorship W2783303183A5078178102 @default.
• W2783303183 hasAuthorship W2783303183A5080425689 @default.
• W2783303183 hasBestOaLocation W27833031831 @default.
• W2783303183 hasConcept C112930515 @default.
• W2783303183 hasConcept C118552586 @default.
• W2783303183 hasConcept C127454912 @default.
• W2783303183 hasConcept C138816342 @default.
• W2783303183 hasConcept C139719470 @default.
• W2783303183 hasConcept C142724271 @default.
• W2783303183 hasConcept C159110408 @default.
• W2783303183 hasConcept C162118730 @default.
• W2783303183 hasConcept C162324750 @default.
• W2783303183 hasConcept C17744445 @default.
• W2783303183 hasConcept C181230689 @default.
• W2783303183 hasConcept C199539241 @default.
• W2783303183 hasConcept C27415008 @default.
• W2783303183 hasConcept C2776125615 @default.
• W2783303183 hasConcept C2778348673 @default.
• W2783303183 hasConcept C2780877353 @default.
• W2783303183 hasConcept C3019080777 @default.
• W2783303183 hasConcept C524218345 @default.
• W2783303183 hasConcept C64332521 @default.
• W2783303183 hasConcept C71924100 @default.
• W2783303183 hasConceptScore W2783303183C112930515 @default.
• W2783303183 hasConceptScore W2783303183C118552586 @default.
• W2783303183 hasConceptScore W2783303183C127454912 @default.
• W2783303183 hasConceptScore W2783303183C138816342 @default.
• W2783303183 hasConceptScore W2783303183C139719470 @default.
• W2783303183 hasConceptScore W2783303183C142724271 @default.
• W2783303183 hasConceptScore W2783303183C159110408 @default.
• W2783303183 hasConceptScore W2783303183C162118730 @default.

• next